Home › Shareholders OK Mylan's inversion deal with Abbott
 

Keywords :   


Shareholders OK Mylan's inversion deal with Abbott

2015-01-29 20:51:09| Biotech - Topix.net

Mylan Inc. shareholders voted Thursday to approve the company's pending acquisition of Abbott's non-U.S. developed markets specialty and branded generic business and reorganization in the Netherlands. Announced in July, the $5.3 billion all-stock transaction gives Abbott a 22 percent stake in Mylan and will move its generic business to a new company that will be headquartered in the tax-friendly Netherlands and called New Mylan.

Tags: deal shareholders abbott inversion

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
21.09Atlantic Tropical Weather Outlook
21.09Eastern North Pacific Tropical Weather Outlook
21.09Atlantic Tropical Weather Outlook
21.09Eastern North Pacific Tropical Weather Outlook
20.09Labelexpo Americas highlights, Maxcess announces acquisition and more
20.09September Cattle on Feed as expected
20.09USDA announces major investment in meat and poultry processing
20.09Atlantic Tropical Weather Outlook
More »